PIN1, a perspective on genetic biomarker for nonalcoholic fatty liver disease (NAFLD)

Objective: A novel genetic and molecular basis of nonalcoholic fatty liver disease (NAFLD) was explored. Study design: A 38-year-old male, who has no bad living and dietary habits, was diagnosed as NAFLD. The potential pathogenic role of Pin1 was evaluated by enzyme-linked immunosorbent (ELISA) assa...

Full description

Bibliographic Details
Main Authors: Jing-Zhang Wang, Yu-Hua Zhang, Jing Bai, Yan-Wei Liu, Wen-Tao Du
Format: Article
Language:English
Published: Elsevier 2019-09-01
Series:Metabolism Open
Online Access:http://www.sciencedirect.com/science/article/pii/S2589936819300143
Description
Summary:Objective: A novel genetic and molecular basis of nonalcoholic fatty liver disease (NAFLD) was explored. Study design: A 38-year-old male, who has no bad living and dietary habits, was diagnosed as NAFLD. The potential pathogenic role of Pin1 was evaluated by enzyme-linked immunosorbent (ELISA) assay and single nucleotide polymorphism (SNP) sequencing. Results: ELISA determined a six-time higher concentration of plasma Pin1 compared to our previous data. Nine PIN1 SNPs were sequenced and classified according to their NAFLD-pathogenic risks, suggesting that rs2233678 and rs2287839 may be the most important genotypes that result in Pin1 overexpression and NAFLD development. Conclusion: In summary, this work explores a novel basis for early-onset NAFLD and highlights that elevated plasma Pin1 may predict NAFLD risk at early stage. Hypothetically, inhibiting Pin1 may benefit NAFLD prevention in the future. Keywords: Nonalcoholic fatty liver disease, Early diagnosis, Pin1, Genetic basis, Plasma biomarker
ISSN:2589-9368